Gold nanorod––siRNA induces efficient in vivo gene silencing in the rat hippocampus. (June 2011)

• Record Type: Journal Article
• Authors: Bonoiu, Adela C; Bergey, Earl J; Ding, Hong; Hu, Rui; Kumar, Rajiv; Yong, Ken-Tye; Prasad, Paras N; Mahajan, Supriya; Picchione, Kelly E; Bhattacharjee, Arin; Ignatowski, Tracey A
• Is Part Of: Nanomedicine. Volume 6:Number 4(2011)
• Page Start: 617
• Page End: 630
• Publication Date: 2011-06
• Subjects: brain -- dark field -- gold nanorod -- hippocampus -- neurological disorder -- rat -- siRNA -- transfection; Nanotechnology -- Periodicals; Medical technology -- Periodicals; Nanotechnology -- Therapeutic use -- Periodicals; 610.28
• DOI: 10.2217/nnm.11.20
• Languages: English
• ISSNs: 1743-5889

Abstract

Aim: Gold nanorods (GNRs), cellular imaging nanoprobes, have been used for drug delivery therapy to immunologically privileged regions in the brain. We demonstrate that nanoplexes formed by electrostatic binding between negatively charged RNA and positively charged GNRs, silence the expression of the target housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) within the CA1 hippocampal region of the rat brain, without showing cytotoxicity.Materials & Methods: Fluorescence imaging with siRNA Cy3 GAPDH and dark-field imaging using plasmonic enhanced scattering from GNRs were used to monitor the distribution of the nanoplexes within different neuronal cell types present in the targeted hippocampal region.Results & Conclusion: Our results show robust nanoplex uptake and slow release of the fluorescent gene silencer with significant impact on the suppression of GAPDH gene expression (70% gene silencing, >10 days postinjection). The observed gene knockdown using nanoplexes in targeted regions of the brain opens a new era of drug treatment for neurological disorders.